[Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations manually curated.
DisGeNET evidence - CURATED